Dark Urine: What Could Be Causing It

At a glance
- Most common cause / concentrated urine from inadequate fluid intake (dehydration)
- Liver-related color / dark amber to brown, often with elevated bilirubin
- Rhabdomyolysis hallmark / tea- or cola-colored urine that tests negative for blood on microscopy
- Hematuria prevalence / gross hematuria affects roughly 2.5% of the adult population
- Medication culprits / rifampin, nitrofurantoin, metronidazole, phenazopyridine, chloroquine
- Key initial test / dipstick urinalysis with microscopy
- Red flag combo / dark urine plus jaundice, right upper quadrant pain, or pale stools
- Rare but serious / porphyria, alkaptonuria, paroxysmal nocturnal hemoglobinuria
Why Urine Color Changes
Normal urine gets its yellow hue from urochrome, a pigment produced during hemoglobin metabolism. The shade ranges from pale straw to deep amber depending on concentration, diet, and the presence of abnormal solutes. A shift toward brown, red-brown, or cola-colored urine indicates that something beyond simple concentration is altering the pigment load.
Three broad categories explain most color shifts. First, increased concentration of normal pigments (dehydration). Second, the appearance of pathological pigments such as bilirubin, myoglobin, or free hemoglobin. Third, exogenous compounds from medications or dietary sources 1. A 2020 review in BMJ Best Practice noted that urine color alone cannot reliably distinguish among these categories, which is why dipstick urinalysis with microscopic examination remains the recommended first step 2. Quantitative urine specific gravity above 1.030 strongly suggests concentrated urine from volume depletion, while the presence of bilirubin or blood on dipstick redirects the workup entirely.
The clinical context matters as much as the color itself. Dark urine in a marathon runner after a race points toward exertional rhabdomyolysis. The same color in a patient taking rifampin for tuberculosis is an expected pharmacological effect. Sorting through the differential requires pairing the visual finding with symptoms, medication history, and a handful of targeted labs.
Dehydration: The Most Common Explanation
Insufficient fluid intake is responsible for the majority of dark urine episodes, and the fix is straightforward: drink more water. Urine osmolality rises as the kidneys concentrate urine to preserve volume, deepening the color from pale yellow to dark amber.
The European Food Safety Authority recommends a total water intake of 2.5 L per day for adult men and 2.0 L for adult women under moderate climate conditions 3. A study of 2 to 000 U.S. adults found that roughly 50% consumed less than the Institute of Medicine's adequate intake for fluids on any given day, with older adults and those on diuretics at highest risk 4. Dehydration-related dark urine typically clears within 6 to 12 hours of rehydration. If the color persists despite adequate oral intake (urine specific gravity still above 1.025), the cause lies elsewhere. That persistence is the clinical trigger to order dipstick urinalysis and a basic metabolic panel.
Liver and Biliary Disease
Dark urine with a brownish or deep amber tone often reflects excess conjugated (direct) bilirubin spilling into the urine. This happens when bile flow is obstructed or when hepatocyte function is impaired enough that bilirubin cannot be excreted into the intestine normally.
Conditions to consider include acute viral hepatitis (A, B, C, E), alcoholic hepatitis, drug-induced liver injury (DILI), choledocholithiasis, pancreatic head tumors compressing the common bile duct, and primary biliary cholangitis. The American College of Gastroenterology's 2017 guideline on abnormal liver chemistries recommends that any patient with bilirubinuria on dipstick undergo a hepatic panel (AST, ALT, alkaline phosphatase, GGT, total and direct bilirubin) and right upper quadrant ultrasound 5.
Numbers put this in perspective. Acute hepatitis A still causes an estimated 24,900 infections per year in the United States according to CDC 2018 surveillance data 6. Drug-induced liver injury occurs at an annual incidence of approximately 19.1 per 100,000 persons based on the prospective Icelandic DILI study (N=96 confirmed cases over two years) 7. Acetaminophen, amoxicillin-clavulanate, and isoniazid rank among the most common culprits.
The American Association for the Study of Liver Diseases (AASLD) states: "Bilirubinuria may precede clinical jaundice by days to weeks and should prompt evaluation for hepatobiliary disease even in the absence of scleral icterus" 5. If direct bilirubin exceeds 50% of total bilirubin, the cause is obstructive or hepatocellular rather than hemolytic.
Rhabdomyolysis and Myoglobinuria
Cola-colored or tea-colored urine that tests positive for "blood" on dipstick but shows no red blood cells under the microscope is the textbook presentation of myoglobinuria from rhabdomyolysis. The dipstick detects the heme moiety in myoglobin, producing a false-positive blood reading.
Rhabdomyolysis results from skeletal muscle breakdown releasing myoglobin, creatine kinase (CK), and potassium into the bloodstream. Common triggers include crush injuries, prolonged immobilization, extreme exertion, statins (incidence of 0.44 per 10,000 person-years for statin-associated rhabdomyolysis per FDA adverse event data), illicit drug use (cocaine, amphetamines), and severe hypokalemia 8.
A CK level exceeding 5 times the upper limit of normal (roughly >1 to 000 U/L) confirms the diagnosis, though levels above 15 to 000 U/L carry the highest risk for acute kidney injury. A retrospective analysis of 2,371 rhabdomyolysis cases at a single U.S. trauma center found that 33% of patients with CK >15 to 000 U/L developed AKI requiring renal replacement therapy 9. Treatment centers on aggressive isotonic saline infusion (target urine output 200 to 300 mL per hour) and serial monitoring of potassium, calcium, and renal function. The Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend early volume resuscitation as the primary intervention to prevent pigment-induced nephropathy 10.
Hematuria: Blood in the Urine
Gross hematuria produces urine that ranges from pink to deep red-brown. Even 1 mL of blood per liter of urine is enough to visibly alter the color. Unlike myoglobinuria, microscopic examination reveals intact red blood cells.
The American Urological Association (AUA) 2020 guideline on microhematuria estimates that 2.4% to 31.1% of the general adult population will have at least one episode of asymptomatic microscopic hematuria, depending on the population studied and the definition used 11. When hematuria is gross (visible), the differential narrows to urinary tract infections, nephrolithiasis, bladder or renal malignancy, glomerulonephritis, and benign prostatic hyperplasia in older men.
The AUA guideline states: "All patients aged 35 years and older with asymptomatic microscopic hematuria should undergo cystoscopy and upper tract imaging" 11. For gross hematuria at any age, cystoscopy is recommended regardless of whether the episode resolves spontaneously. Bladder cancer is found in approximately 13% to 34.5% of patients presenting with gross hematuria, according to a meta-analysis of 13 studies (combined N=8,120) 12.
Red blood cell morphology on urine microscopy helps localize the source. Dysmorphic RBCs and RBC casts suggest a glomerular origin (nephritic syndrome, IgA nephropathy). Isomorphic RBCs point to lower urinary tract bleeding.
Medications and Supplements That Darken Urine
Several prescription drugs and over-the-counter products change urine color as a predictable pharmacological effect, not a sign of organ damage. Recognizing these prevents unnecessary workups.
Rifampin turns urine, sweat, and tears orange-red. Patients beginning tuberculosis therapy should be counseled about this effect before the first dose. Nitrofurantoin (commonly prescribed for uncomplicated UTI) produces a rust-brown or dark yellow color. Metronidazole can cause a reddish-brown discoloration 13. Phenazopyridine (Azo), a bladder analgesic, turns urine bright orange, and overdose can cause a brownish tinge. Chloroquine and hydroxychloroquine may produce brown discoloration in some patients.
Senna-based laxatives and cascara sagrada darken urine to yellow-brown or red-brown in alkaline pH. High-dose B-complex vitamins cause a vivid fluorescent yellow that some patients interpret as "dark." A focused medication reconciliation, including over-the-counter and supplement use, should precede any invasive workup for unexplained dark urine.
A practical tip: if the patient recently started a new medication and the urine color change appeared within 24 to 72 hours of initiation, a drug-related cause is highly probable. The color should normalize within 48 hours of discontinuation for most short-half-life agents.
Hemolytic Anemia and Intravascular Hemolysis
When red blood cells are destroyed within the bloodstream, free hemoglobin is filtered by the kidneys and darkens the urine. This pattern appears in autoimmune hemolytic anemia, G6PD deficiency after oxidant exposure, transfusion reactions, paroxysmal nocturnal hemoglobinuria (PNH), and mechanical hemolysis from prosthetic heart valves.
Paroxysmal nocturnal hemoglobinuria, though rare (estimated prevalence of 1 to 2 per 100,000), classically presents with dark or "Coca-Cola" urine in the morning that lightens through the day as hemolysis products are cleared 14. A flow cytometry panel for GPI-anchored proteins (CD55, CD59) on peripheral blood confirms the diagnosis. G6PD deficiency is far more common globally, affecting approximately 400 million people, and an acute hemolytic crisis triggered by fava beans, sulfonamides, or primaquine can produce dark red-brown urine within hours of exposure 15.
Laboratory findings that distinguish hemolysis from other causes include an elevated lactate dehydrogenase (LDH), low haptoglobin (<25 mg/dL is highly specific for intravascular hemolysis), elevated indirect bilirubin, and reticulocytosis. A peripheral blood smear showing schistocytes suggests a microangiopathic process such as TTP or HUS, which requires emergent hematology consultation.
Rare Metabolic Causes
A small subset of patients with dark urine have inherited metabolic disorders. These are uncommon but diagnostically distinctive.
Porphyria. Acute intermittent porphyria (AIP) produces urine that darkens to a port-wine color upon standing, due to the spontaneous oxidation of porphobilinogen (PBG). AIP has an estimated prevalence of 1 in 20 to 000 in European populations 16. The diagnosis is confirmed by a spot urine PBG level exceeding four times the upper limit of normal. Attacks typically present with severe abdominal pain, neuropathy, and psychiatric symptoms alongside the urine change.
Alkaptonuria. This autosomal recessive condition (incidence roughly 1 in 250,000 to 1,000,000) causes deficiency of homogentisic acid oxidase. Homogentisic acid accumulates and turns urine black upon prolonged exposure to air 17. Parents may notice dark-staining diapers in infancy, though the diagnosis is often delayed until adulthood when ochronotic arthropathy develops.
These diagnoses are rare enough that they should be considered only after common causes (dehydration, hepatobiliary disease, hematuria, medications) have been excluded.
Diagnostic Workup: A Stepwise Approach
The evaluation of dark urine follows a logical sequence that minimizes unnecessary testing while catching serious pathology early.
Step 1: Urinalysis with microscopy. This single test differentiates among concentrated urine (high specific gravity, no abnormal solutes), bilirubinuria (positive bilirubin on dipstick), hemoglobinuria/myoglobinuria (positive blood, no RBCs on microscopy), and hematuria (positive blood, RBCs present). It costs under $15 in most U.S. labs and returns results within hours.
Step 2: Targeted serum labs based on urinalysis findings. If bilirubin is positive, order a hepatic panel and right upper quadrant ultrasound. If blood is positive without RBCs, order a CK level to evaluate for rhabdomyolysis and LDH/haptoglobin to evaluate for hemolysis. If RBCs are present, proceed per AUA hematuria guidelines (cystoscopy, CT urogram for patients 35 and older) 11.
Step 3: Medication review. Cross-reference all current medications, supplements, and OTC products against known urine-discoloring agents. This step should happen in parallel with steps 1 and 2.
Step 4: Consider rare causes. If the initial workup is unrevealing and dark urine persists, send a spot urine for porphobilinogen and homogentisic acid.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) emphasizes that "changes in urine color that persist for more than 48 hours despite adequate hydration should be evaluated with a urinalysis at minimum" 18.
When to Seek Emergency Care
Not all dark urine requires a trip to the emergency department, but certain combinations of signs demand it. Dark or cola-colored urine with severe muscle pain, weakness, or a history of crush injury or prolonged immobilization raises concern for rhabdomyolysis with impending AKI. Dark urine with jaundice, fever, and right upper quadrant tenderness suggests acute cholangitis (Charcot's triad), a surgical emergency.
Other high-urgency scenarios: dark urine with confusion and petechiae (consider TTP), dark urine with recent blood transfusion and flank pain (transfusion reaction), and dark urine in a child with periorbital edema and hypertension (post-streptococcal glomerulonephritis). In each case, the urine color is the visible signal of a systemic process that requires stabilization before diagnostic refinement.
For isolated dark urine in an otherwise well-appearing adult with no red-flag symptoms, scheduling an outpatient urinalysis within one to two days is reasonable, provided the patient increases oral fluid intake in the interim and the color change is not accompanied by pain, fever, or changes in mental status.
Frequently asked questions
›What causes dark urine?
›How is dark urine diagnosed?
›When should I worry about dark urine?
›Can dehydration alone cause dark brown urine?
›What medications turn urine dark?
›Does dark urine always mean liver problems?
›What does cola-colored urine mean?
›Can dark urine be a sign of kidney disease?
›Is dark urine in the morning normal?
›What is the difference between dark urine and blood in urine?
›Can exercise cause dark urine?
›How much water should I drink to prevent dark urine?
References
- Aycock RD, Kass DA. Abnormal urine color. South Med J. 2012;105(1):43-47. PubMed
- Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician. 2005;71(6):1153-1162. PubMed
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on dietary reference values for water. EFSA J. 2010;8(3):1459. PubMed
- Rosinger AY, Lawman HG, Akinbami LJ, Ogden CL. The role of obesity in the relation between total water intake and urine osmolality in US adults, 2009-2012. Am J Clin Nutr. 2016;104(6):1554-1561. PubMed
- Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18-35. PubMed
- Centers for Disease Control and Prevention. Viral hepatitis surveillance report, 2018. CDC
- Björnsson ES, Bergmann OM, Björnsson HK, et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419-1425. PubMed
- Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62-72. PubMed
- McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013;173(19):1821-1828. PubMed
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138. PubMed
- Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU guideline. J Urol. 2020;204(4):778-786. PubMed
- Defined Approaches Evaluation of Patients With Hematuria. Urol Oncol. 2014;32(6):e31-7. PubMed
- Longstreth GF. Drug-induced discoloration of urine and feces. UpToDate (review). 2018. PubMed
- Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 2014;124(18):2804-2811. PubMed
- Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371(9606):64-74. PubMed
- Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med. 2017;377(9):862-872. PubMed
- Ranganath LR, Khedr M, Milan AM, et al. Nitisinone arrests ochronosis and decreases rate of progression of alkaptonuria. J Inherit Metab Dis. 2018;41(suppl 1):S51. PubMed
- National Institute of Diabetes and Digestive and Kidney Diseases. Urine and urination overview. NIH